2022 Q3 Form 10-Q Financial Statement

#000121390022046325 Filed on August 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $26.14M $36.55M $28.96M
YoY Change -15.29% 19.09% -11.67%
Cost Of Revenue $18.75M $18.21M $19.16M
YoY Change 3.16% -56.78% -14.96%
Gross Profit $7.395M $18.34M $9.795M
YoY Change -41.72% -14.06% -4.54%
Gross Profit Margin 28.29% 50.18% 33.83%
Selling, General & Admin $5.497M $7.280M $5.158M
YoY Change 22.23% -22.58% 8.82%
% of Gross Profit 74.34% 39.69% 52.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.081M $1.121M $20.10M
YoY Change -93.87% 66.92% -8.02%
% of Gross Profit 14.62% 6.11% 205.19%
Operating Expenses $11.94M $13.34M $11.08M
YoY Change 35.36% -28.79% 25.17%
Operating Profit -$4.549M $5.003M -$1.283M
YoY Change -217.66% 313.09% -190.97%
Interest Expense $3.030M $2.348M -$1.958M
YoY Change -345.63% 92.07% 39.86%
% of Operating Profit 46.93%
Other Income/Expense, Net
YoY Change
Pretax Income -$7.579M $2.655M -$3.241M
YoY Change -387.92% 38.24%
Income Tax -$1.298M -$11.73M -$859.8K
% Of Pretax Income -442.02%
Net Earnings -$6.280M $14.39M -$2.381M
YoY Change -470.3% 1427.2% -192576.56%
Net Earnings / Revenue -24.02% 39.37% -8.22%
Basic Earnings Per Share -$0.32 $0.63 -$0.14
Diluted Earnings Per Share -$0.32 $0.51 -$110.5K
COMMON SHARES
Basic Shares Outstanding 21.61M shares 21.61M shares 21.55M shares
Diluted Shares Outstanding 21.68M shares 27.90M shares 21.55M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.274M $4.988M $4.320M
YoY Change 67.55% -3.09% -31.65%
Cash & Equivalents $5.274M $4.988M $4.320M
Short-Term Investments
Other Short-Term Assets $32.61M $37.71M $37.53M
YoY Change -5.33% -2.5% -6.73%
Inventory
Prepaid Expenses $1.479M $1.114M
Receivables $33.43M $33.05M $29.54M
Other Receivables $22.53M $7.138M
Total Short-Term Assets $97.90M $98.29M $78.52M
YoY Change 71.01% 72.51% 36.35%
LONG-TERM ASSETS
Property, Plant & Equipment $7.416M $9.400M $8.424M
YoY Change 2.62% 59.99% 41.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.33M $12.32M $76.81K
YoY Change 19471.65% 18426.48% 9.73%
Total Long-Term Assets $24.20M $21.72M $8.501M
YoY Change 231.21% 265.55% 41.44%
TOTAL ASSETS
Total Short-Term Assets $97.90M $98.29M $78.52M
Total Long-Term Assets $24.20M $21.72M $8.501M
Total Assets $122.1M $120.0M $87.03M
YoY Change 89.14% 90.74% 36.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.875M $5.242M $4.817M
YoY Change 15.89% 37.88% 53.89%
Accrued Expenses $3.244M $4.777M $2.416M
YoY Change -23.35% 38.92% -32.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.191M $1.177M $233.9K
YoY Change -75.24% -75.54% -82.8%
Total Short-Term Liabilities $9.204M $11.79M $7.467M
YoY Change -25.7% -2.14% -7.24%
LONG-TERM LIABILITIES
Long-Term Debt $88.02M $77.51M $63.46M
YoY Change 157.21% 119.68% 52.22%
Other Long-Term Liabilities $178.2K $178.2K $1.715M
YoY Change -91.14% -91.32% -17.94%
Total Long-Term Liabilities $178.2K $178.2K $65.18M
YoY Change -99.51% -99.52% 48.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.204M $11.79M $7.467M
Total Long-Term Liabilities $178.2K $178.2K $65.18M
Total Liabilities $99.02M $91.15M $72.82M
YoY Change 100.77% 83.16% 40.47%
SHAREHOLDERS EQUITY
Retained Earnings -$39.49M -$33.21M
YoY Change
Common Stock $2.176K $2.161K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.08M $28.85M $14.20M
YoY Change
Total Liabilities & Shareholders Equity $122.1M $120.0M $87.03M
YoY Change 89.14% 90.74% 36.83%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.280M $14.39M -$2.381M
YoY Change -470.3% 1427.2% -192576.56%
Depreciation, Depletion And Amortization $1.081M $1.121M $20.10M
YoY Change -93.87% 66.92% -8.02%
Cash From Operating Activities -$7.874M -$11.73M -$7.941M
YoY Change -759.36% -2331.74% 1317.98%
INVESTING ACTIVITIES
Capital Expenditures -$2.389M -$2.133M -$1.554M
YoY Change 14.16% 234.84% 112.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.389M -$2.133M -$1.554M
YoY Change 14.16% 234.84% 112.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.57M 14.99M 8.720M
YoY Change -1059.75% -1511.24% -1037.58%
NET CHANGE
Cash From Operating Activities -7.874M -11.73M -7.941M
Cash From Investing Activities -2.389M -2.133M -1.554M
Cash From Financing Activities 10.57M 14.99M 8.720M
Net Change In Cash 306.1K 1.130M -774.9K
YoY Change -115.31% -196.27% -65.09%
FREE CASH FLOW
Cash From Operating Activities -$7.874M -$11.73M -$7.941M
Capital Expenditures -$2.389M -$2.133M -$1.554M
Free Cash Flow -$5.485M -$9.597M -$6.387M
YoY Change -266.91% -925.37% -3856.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37945
dei Entity Registrant Name
EntityRegistrantName
FlexShopper, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5456087
dei Entity Address Address Line1
EntityAddressAddressLine1
901 Yamato Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 260
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33431
dei City Area Code
CityAreaCode
(855)
dei Local Phone Number
LocalPhoneNumber
353-9289
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
FPAY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21605234 shares
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
4988308 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
4986559 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
461649 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
108083 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33050840 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26338883 usd
CY2022Q2 us-gaap Securities Received As Collateral
SecuritiesReceivedAsCollateral
22534033 usd
CY2021Q4 us-gaap Securities Received As Collateral
SecuritiesReceivedAsCollateral
3560108 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1113554 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
957527 usd
CY2022Q2 fpay Lease Merchandise
LeaseMerchandise
36136995 usd
CY2021Q4 fpay Lease Merchandise
LeaseMerchandise
40942112 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
98285379 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
76893272 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9399753 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7841206 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
76040 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
77578 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12244068 usd
CY2022Q2 us-gaap Assets
Assets
120005240 usd
CY2021Q4 us-gaap Assets
Assets
84812056 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5242163 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7982180 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
416734 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
391078 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Premium Noncurrent
DebtInstrumentUnamortizedPremiumNoncurrent
0 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Premium Noncurrent
DebtInstrumentUnamortizedPremiumNoncurrent
1274 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1167871 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1053088 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4777278 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2987646 usd
CY2022Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
189804 usd
CY2021Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
172732 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11793850 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12586724 usd
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
394396 usd
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
413076 usd
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
66755604 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
50061924 usd
CY2022Q2 fpay Promissory Notes To Related Parties Net Of Current Portion
PromissoryNotesToRelatedPartiesNetOfCurrentPortion
10750000 usd
CY2021Q4 fpay Promissory Notes To Related Parties Net Of Current Portion
PromissoryNotesToRelatedPartiesNetOfCurrentPortion
3750000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
178160 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
495166 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1675959 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1774623 usd
CY2022Q2 us-gaap Liabilities
Liabilities
91153573 usd
CY2021Q4 us-gaap Liabilities
Liabilities
68668437 usd
CY2022Q2 fpay Convertible Preferred Stock Series
ConvertiblePreferredStockSeries
851660 usd
CY2021Q4 fpay Convertible Preferred Stock Series
ConvertiblePreferredStockSeries
851660 usd
CY2022Q2 fpay Convertible Preferred Stock Serie Two
ConvertiblePreferredStockSerieTwo
21952000 usd
CY2021Q4 fpay Convertible Preferred Stock Serie Two
ConvertiblePreferredStockSerieTwo
21952000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21605234 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21605234 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21442278 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21442278 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2161 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2144 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39259862 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38560117 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33214016 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45222302 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
28851667 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16143619 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120005240 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84812056 usd
CY2022Q2 fpay Lease Revenues And Fees Net
LeaseRevenuesAndFeesNet
30468476 usd
CY2021Q2 fpay Lease Revenues And Fees Net
LeaseRevenuesAndFeesNet
30662470 usd
fpay Lease Revenues And Fees Net
LeaseRevenuesAndFeesNet
58234788 usd
fpay Lease Revenues And Fees Net
LeaseRevenuesAndFeesNet
63413801 usd
CY2022Q2 fpay Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount
NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount
6079675 usd
CY2021Q2 fpay Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount
NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount
26083 usd
fpay Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount
NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount
7268599 usd
fpay Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount
NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount
58422 usd
CY2022Q2 us-gaap Revenues
Revenues
36548151 usd
CY2021Q2 us-gaap Revenues
Revenues
30688553 usd
us-gaap Revenues
Revenues
65503387 usd
us-gaap Revenues
Revenues
63472223 usd
CY2022Q2 fpay Cost Of Lease Revenues Fees
CostOfLeaseRevenuesFees
18207305 usd
CY2021Q2 fpay Cost Of Lease Revenues Fees
CostOfLeaseRevenuesFees
19490864 usd
fpay Cost Of Lease Revenues Fees
CostOfLeaseRevenuesFees
37367916 usd
fpay Cost Of Lease Revenues Fees
CostOfLeaseRevenuesFees
41954420 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
804228 usd
CY2021Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
111787 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1229741 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
175184 usd
CY2022Q2 us-gaap Marketing Expense
MarketingExpense
3770820 usd
CY2021Q2 us-gaap Marketing Expense
MarketingExpense
1914095 usd
us-gaap Marketing Expense
MarketingExpense
5784935 usd
us-gaap Marketing Expense
MarketingExpense
3746835 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3014920 usd
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2747005 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
5979362 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
5656324 usd
CY2022Q2 us-gaap Other General Expense
OtherGeneralExpense
5748286 usd
CY2021Q2 us-gaap Other General Expense
OtherGeneralExpense
5213789 usd
us-gaap Other General Expense
OtherGeneralExpense
11421488 usd
us-gaap Other General Expense
OtherGeneralExpense
9328213 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
31545559 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
29477540 usd
us-gaap Costs And Expenses
CostsAndExpenses
61783442 usd
us-gaap Costs And Expenses
CostsAndExpenses
60860976 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5002592 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1211013 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3719945 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2611247 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1931825 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1931825 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
2347838 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
1222400 usd
us-gaap Interest Expense
InterestExpense
4305906 usd
us-gaap Interest Expense
InterestExpense
2621397 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2654754 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1920438 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-585961 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1921675 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11734467 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
978244 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12594247 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
978244 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
14389221 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
942194 usd
us-gaap Net Income Loss
NetIncomeLoss
12008286 usd
us-gaap Net Income Loss
NetIncomeLoss
943431 usd
CY2022Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
609777 usd
CY2021Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
609773 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1219554 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1219545 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13779444 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
332421 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10788732 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-276114 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1237 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11761381 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
249222 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
191926 usd
CY2021Q2 fpay Exercise Of Warrants Into Common Stock
ExerciseOfWarrantsIntoCommonStock
4214 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21605234 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21605461 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21576312 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21375096 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27898824 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23603477 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28193268 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21375096 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16143619 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
305229 usd
CY2022Q1 fpay Exercise Of Warrants Into Common Stock
ExerciseOfWarrantsIntoCommonStock
137057 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2380935 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
14204970 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
257476 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
14389221 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
28851667 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11154046 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
380263 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
212923 usd
CY2021Q1 fpay Exercise Of Warrants Into Common Stock
ExerciseOfWarrantsIntoCommonStock
12912 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
942194 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
13148937 usd
us-gaap Net Income Loss
NetIncomeLoss
12008286 usd
us-gaap Net Income Loss
NetIncomeLoss
943431 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
37367916 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
39064981 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
2059323 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1324049 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
106886 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
134580 usd
us-gaap Share Based Compensation
ShareBasedCompensation
562705 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1034334 usd
fpay Provisions For Doubtful Accounts
ProvisionsForDoubtfulAccounts
-27563993 usd
fpay Provisions For Doubtful Accounts
ProvisionsForDoubtfulAccounts
-18778392 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-6604507 usd
fpay Interest In Kind Added To Promissory Notes Balance
InterestInKindAddedToPromissoryNotesBalance
113509 usd
fpay Interest In Kind Added To Promissory Notes Balance
InterestInKindAddedToPromissoryNotesBalance
9461 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12561074 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
378859 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
17800000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3500000 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
1125000 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
4975000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
86932 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
526565 usd
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
1931825 usd
fpay Net Changes In The Fair Value Of Loans Receivable At Fair Value
NetChangesInTheFairValueOfLoansReceivableAtFairValue
-2457851 usd
fpay Net Changes In The Fair Value Of Loans Receivable At Fair Value
NetChangesInTheFairValueOfLoansReceivableAtFairValue
58575 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40880457 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21775777 usd
fpay Increase Decrease In Loans Receivable At Fair Value
IncreaseDecreaseInLoansReceivableAtFairValue
16516074 usd
fpay Increase Decrease In Loans Receivable At Fair Value
IncreaseDecreaseInLoansReceivableAtFairValue
179141 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
155773 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
174222 usd
fpay Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
32562799 usd
fpay Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
33875960 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
4280 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5091 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2598 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2740017 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4105547 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
25656 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
438010 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1794983 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-158248 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19671372 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34366 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3687241 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1367154 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3687241 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1367154 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
137057 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17126 usd
fpay Proceeds From Debt Instrument
ProceedsFromDebtInstrument
7000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5592 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2457 usd
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
5605 usd
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
5603 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23713928 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1992499 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
355315 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3394019 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5094642 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8541232 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5449957 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5147213 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
3953765 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2506589 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Estimates -</b> The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4988308 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4986559 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
461649 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
108083 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5449957 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5094642 usd
CY2022Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
47515013 usd
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
54042161 usd
CY2022Q2 fpay Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
-14464173 usd
CY2021Q4 fpay Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
-27703278 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
33050840 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
26338883 usd
CY2022Q2 fpay Accounts Receivable Charged Off Against Allowance
AccountsReceivableChargedOffAgainstAllowance
23719531 usd
fpay Accounts Receivable Charged Off Against Allowance
AccountsReceivableChargedOffAgainstAllowance
40803098 usd
CY2021Q2 fpay Accounts Receivable Charged Off Against Allowance
AccountsReceivableChargedOffAgainstAllowance
1980196 usd
fpay Accounts Receivable Charged Off Against Allowance
AccountsReceivableChargedOffAgainstAllowance
9016360 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
27703278 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
22138541 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27563993 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
40342618 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
40803098 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
34777881 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14464173 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
27703278 usd
CY2022Q2 fpay Lease Merchandise At Cost
LeaseMerchandiseAtCost
69525102 usd
CY2021Q4 fpay Lease Merchandise At Cost
LeaseMerchandiseAtCost
72159063 usd
CY2022Q2 fpay Accumulated Depreciation
AccumulatedDepreciation
30307129 usd
CY2021Q4 fpay Accumulated Depreciation
AccumulatedDepreciation
29505431 usd
CY2022Q2 fpay Impairment Reserve
ImpairmentReserve
3080978 usd
CY2021Q4 fpay Impairment Reserve
ImpairmentReserve
1711520 usd
CY2022Q2 fpay Lease Merchandise Net
LeaseMerchandiseNet
36136995 usd
CY2021Q4 fpay Lease Merchandise Net
LeaseMerchandiseNet
40942112 usd
CY2022Q2 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
2981275 usd
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
2457851 usd
CY2021Q2 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
41583 usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
58575 usd
CY2022Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
39596845 usd
CY2021Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
40607513 usd
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
79194274 usd
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
82192193 usd
CY2022Q2 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
15732876 usd
CY2021Q2 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
9945043 usd
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
27563993 usd
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
18778392 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-6604507 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-6604507 usd
CY2022Q2 fpay Lease Revenues And Fees
LeaseRevenuesAndFees
30468476 usd
CY2021Q2 fpay Lease Revenues And Fees
LeaseRevenuesAndFees
30662470 usd
fpay Lease Revenues And Fees
LeaseRevenuesAndFees
58234788 usd
fpay Lease Revenues And Fees
LeaseRevenuesAndFees
63413801 usd
CY2022Q2 fpay Interest Expense Debt Including Amortization
InterestExpenseDebtIncludingAmortization
56283 usd
fpay Interest Expense Debt Including Amortization
InterestExpenseDebtIncludingAmortization
105612 usd
CY2021Q2 fpay Interest Expense Debt Including Amortization
InterestExpenseDebtIncludingAmortization
41603 usd
fpay Interest Expense Debt Including Amortization
InterestExpenseDebtIncludingAmortization
130124 usd
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
769 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1538 usd
CY2022Q2 us-gaap Payments For Software
PaymentsForSoftware
1285088 usd
us-gaap Payments For Software
PaymentsForSoftware
2270082 usd
CY2021Q2 us-gaap Payments For Software
PaymentsForSoftware
526723 usd
us-gaap Payments For Software
PaymentsForSoftware
1115715 usd
CY2022Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
683161 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1304855 usd
CY2021Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
583437 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1154004 usd
CY2022Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
469650 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
762704 usd
CY2021Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
0 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
0 usd
CY2022Q2 fpay Capitalized Data Costs Amortization Expense
CapitalizedDataCostsAmortizationExpense
120938 usd
fpay Capitalized Data Costs Amortization Expense
CapitalizedDataCostsAmortizationExpense
209659 usd
CY2021Q2 fpay Capitalized Data Costs Amortization Expense
CapitalizedDataCostsAmortizationExpense
0 usd
fpay Capitalized Data Costs Amortization Expense
CapitalizedDataCostsAmortizationExpense
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13169423 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11657627 shares
fpay Net Incomelosses
NetIncomelosses
12008286 usd
fpay Net Incomelosses
NetIncomelosses
943431 usd
fpay Convertible Series2 Preferred Share Dividends
ConvertibleSeries2PreferredShareDividends
-1219554 usd
fpay Convertible Series2 Preferred Share Dividends
ConvertibleSeries2PreferredShareDividends
-1219545 usd
fpay Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock
NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock
10788732 usd
fpay Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock
NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock
-276114 usd
fpay Net Income Attributables To Series1 Convertible Preferred Stock
NetIncomeAttributablesToSeries1ConvertiblePreferredStock
-124057 usd
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
12599 usd
fpay Numerator For Basic And Diluted Eps
NumeratorForBasicAndDilutedEPS
10677274 usd
fpay Numerator For Basic And Diluted Eps
NumeratorForBasicAndDilutedEPS
-276114 usd
fpay Series2 Convertible Preferred Stock Dividends
Series2ConvertiblePreferredStockDividends
1219554 usd
fpay Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps
NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps
11896828 usd
fpay Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps
NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps
-276114 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21576312 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21375096 shares
fpay Number Of Series Two Convertible Preferred Stock
NumberOfSeriesTwoConvertiblePreferredStock
5845695 usd
fpay Number Of Series One Convertible Preferred Stock
NumberOfSeriesOneConvertiblePreferredStock
225231 usd
fpay Common Stock Optionsin Shares
CommonStockOptionsinShares
355753 shares
fpay Common Stock Warrantsin Shares
CommonStockWarrantsinShares
190277 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
28193268 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21375096 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 fpay Net Incomelosses
NetIncomelosses
14389221 usd
CY2021Q2 fpay Net Incomelosses
NetIncomelosses
942194 usd
CY2022Q2 fpay Convertible Series2 Preferred Share Dividends
ConvertibleSeries2PreferredShareDividends
-609777 usd
CY2021Q2 fpay Convertible Series2 Preferred Share Dividends
ConvertibleSeries2PreferredShareDividends
-609773 usd
CY2022Q2 fpay Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock
NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock
13779444 usd
CY2021Q2 fpay Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock
NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock
332421 usd
CY2022Q2 fpay Net Income Attributables To Series1 Convertible Preferred Stock
NetIncomeAttributablesToSeries1ConvertiblePreferredStock
-148457 usd
CY2021Q2 fpay Net Income Attributables To Series1 Convertible Preferred Stock
NetIncomeAttributablesToSeries1ConvertiblePreferredStock
-9822 usd
CY2022Q2 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
6291 usd
CY2021Q2 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
6357 usd
CY2022Q2 fpay Numerator For Basic And Diluted Eps
NumeratorForBasicAndDilutedEPS
13637278 usd
CY2021Q2 fpay Numerator For Basic And Diluted Eps
NumeratorForBasicAndDilutedEPS
328956 usd
CY2021Q2 fpay Common Stock Optionsin Shares
CommonStockOptionsinShares
1156512 shares
CY2021Q2 fpay Common Stock Warrantsin Shares
CommonStockWarrantsinShares
841504 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
27898824 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
23603477 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q2 fpay Series2 Convertible Preferred Stock Dividends
Series2ConvertiblePreferredStockDividends
609777 usd
CY2022Q2 fpay Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps
NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps
14247055 usd
CY2021Q2 fpay Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps
NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps
328956 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21605234 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21605461 shares
CY2022Q2 fpay Number Of Series Two Convertible Preferred Stock
NumberOfSeriesTwoConvertiblePreferredStock
5845695 usd
CY2022Q2 fpay Number Of Series One Convertible Preferred Stock
NumberOfSeriesOneConvertiblePreferredStock
225231 usd
CY2022Q2 fpay Common Stock Optionsin Shares
CommonStockOptionsinShares
222664 shares
CY2022Q2 us-gaap Fair Value Option Loans Held As Assets90 Days Or More Past Due Aggregate Difference
FairValueOptionLoansHeldAsAssets90DaysOrMorePastDueAggregateDifference
217398 usd
CY2022Q2 us-gaap Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status Aggregated Difference
FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatusAggregatedDifference
661727 usd
fpay Largest Benefit Percentage
LargestBenefitPercentage
0.50 pure
fpay Operating Leases Rent Expense Monthly Rent
OperatingLeasesRentExpenseMonthlyRent
2300 usd
CY2019Q1 fpay Term Of Lease
TermOfLease
P108M
CY2019Q1 us-gaap Area Of Land
AreaOfLand
21622 sqm
CY2019Q1 fpay Conversion Of Stock Options Into Common Stock
ConversionOfStockOptionsIntoCommonStock
31500 usd
CY2019Q1 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.03 pure
CY2021Q3 us-gaap Payments For Rent
PaymentsForRent
6900 usd
fpay Operating Leases Rent Expense
OperatingLeasesRentExpense
339000 usd
fpay Operating Leases Rent Expense
OperatingLeasesRentExpense
324000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
210000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
427000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
435000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
443000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
456000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
774000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2745000 usd
CY2022Q2 fpay Total Lease Assets
TotalLeaseAssets
1482421 usd
CY2021Q4 fpay Total Lease Assets
TotalLeaseAssets
1553330 usd
CY2022Q2 fpay Total Lease Liabilities
TotalLeaseLiabilities
1865763 usd
CY2021Q4 fpay Total Lease Liabilities
TotalLeaseLiabilities
1947355 usd
fpay Term Of Lease
TermOfLease
P12M
us-gaap Operating Lease Cost
OperatingLeaseCost
195033 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
201171 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
200714 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
202007 usd
fpay Finance Lease Principal Payment
FinanceLeasePrincipalPayment
5592 usd
fpay Finance Lease Principal Payment
FinanceLeasePrincipalPayment
5592 usd
CY2022Q2 fpay Operating Lease Future Minimum Payments Due Current
OperatingLeaseFutureMinimumPaymentsDueCurrent
204729 usd
CY2022Q2 fpay Operating Lease Future Minimum Payments Due In Two Years
OperatingLeaseFutureMinimumPaymentsDueInTwoYears
417606 usd
CY2022Q2 fpay Operating Lease Future Minimum Payments Due In Three Years
OperatingLeaseFutureMinimumPaymentsDueInThreeYears
430134 usd
CY2022Q2 fpay Operating Lease Future Minimum Payments Due In Four Years
OperatingLeaseFutureMinimumPaymentsDueInFourYears
443038 usd
CY2022Q2 fpay Operating Lease Future Minimum Payments Due In Five Years
OperatingLeaseFutureMinimumPaymentsDueInFiveYears
456330 usd
CY2022Q2 fpay Operating Lease Future Minimum Payments Due Thereafter
OperatingLeaseFutureMinimumPaymentsDueThereafter
773594 usd
CY2022Q2 fpay Operating Lease Future Minimum Payments Due
OperatingLeaseFutureMinimumPaymentsDue
2725431 usd
CY2022Q2 fpay Interest
Interest
-877274 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1848157 usd
fpay Schedule Of Undiscounted Finance Lease Liabilities
ScheduleOfUndiscountedFinanceLeaseLiabilities
<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-variant: small-caps"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>Finance Leases</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; font-size: 10pt; text-align: left">2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,591</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,699</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,782</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Total undiscounted cash flows</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,072</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">Less: interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,466</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; font-size: 10pt">Present value of lease liabilities</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,606</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>
CY2022Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
5591 usd
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
9699 usd
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
4782 usd
CY2022Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
20072 usd
fpay Finance Leaseinterest
FinanceLeaseinterest
2466 usd
CY2022Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
17606 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22547064 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18859823 usd
CY2022Q2 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
14629732 usd
CY2021Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
12571947 usd
CY2022Q2 us-gaap Assets Net
AssetsNet
1482421 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
1553330 usd
CY2022Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
9399753 usd
CY2021Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
7841206 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1121492 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
671887 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2057785 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1322514 usd
fpay Principal Accrued Unpaid Interestoutstanding
PrincipalAccruedUnpaidInterestoutstanding
1014287 usd
fpay Principal Accrued Unpaid Interestoutstanding
PrincipalAccruedUnpaidInterestoutstanding
1011879 usd
CY2022Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
69428 usd
CY2021Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
36778 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
102144 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
76744 usd
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
42462 usd
CY2021Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
36122 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
104991 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
73111 usd
fpay Description Of Notes Amended And Restated
DescriptionOfNotesAmendedAndRestated
This last amendment extended the maturity date from April 1, 2022 to July 1, 2024 and increased the credit commitment from $3,750,000 to $11,000,000.
CY2021Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
237000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
249222 usd
fpay Schedule Of Covenant Requirements And Flexshoppers Actual Results
ScheduleOfCovenantRequirementsAndFlexshoppersActualResults
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Required<br/> Covenant</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Actual <br/> Position</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Equity Book Value not less than</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,636,387</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">28,851,667</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Liquidity greater than</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,988,308</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash greater than</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,449,957</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Consolidated Total Debt to Equity Book Value ratio not to exceed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.71</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
fpay Warrants Granted
WarrantsGranted
240000 shares
fpay Issuance Of Shares And Warrants In Eauity Raise Value
IssuanceOfSharesAndWarrantsInEauityRaiseValue
404849 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.69
fpay Warrant Convertible Into Common Stock
WarrantConvertibleIntoCommonStock
116903 shares
CY2022Q2 fpay Stock Options
StockOptions
232824 usd
CY2021Q2 fpay Stock Options
StockOptions
249222 usd
fpay Stock Options
StockOptions
524107 usd
fpay Stock Options
StockOptions
629486 usd
CY2022Q2 fpay Performance Share Units
PerformanceShareUnits
-24652 usd
fpay Performance Share Units
PerformanceShareUnits
-38598 usd
CY2022Q2 fpay Total Stockbased Compensation
TotalStockbasedCompensation
257476 usd
CY2021Q2 fpay Total Stockbased Compensation
TotalStockbasedCompensation
249222 usd
fpay Total Stockbased Compensation
TotalStockbasedCompensation
562705 usd
fpay Total Stockbased Compensation
TotalStockbasedCompensation
629486 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
257476 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
562705 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3080904 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1923642 usd
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3117310 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.03
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
629485 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1657894 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.676 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.93 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1050468 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
162956 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.84
fpay Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue
204030 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7333 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.22
CY2022Q2 fpay Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue
2273 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
25000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.7
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3936083 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.96
fpay Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2
P7Y2M1D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
39412 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2707122 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.06
fpay Sharebased Compensation Arrangement By Sharebased Payment Award Option Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3
P6Y6M29D
CY2022Q2 fpay Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue1
39412 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2595700 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.92
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2491026 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
568278 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
21333 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.8
fpay Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue
48496 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25335 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.28
CY2021Q2 fpay Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue
30987 usd
fpay Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2
P7Y2M1D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3555431 usd
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2084461 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.01
fpay Sharebased Compensation Arrangement By Sharebased Payment Award Option Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3
P7Y2M8D
CY2021Q2 fpay Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue1
2635699 usd
fpay Weighted Average Grant Fair Value
WeightedAverageGrantFairValue
0.89
fpay Weighted Average Grant Fair Value
WeightedAverageGrantFairValue
1.77
fpay Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1
790327 shares
fpay Weighted Average Grant Date Fair Value Granted
WeightedAverageGrantDateFairValueGranted
P1Y6M10D
fpay Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1
790327 shares
fpay Weighted Average Grant Date Fair Value Non Vested1
WeightedAverageGrantDateFairValueNonVested1
P1Y6M10D
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12500000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
56375431 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
4878909 usd
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
0.21 usd
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>11. CONTINGENCIES AND OTHER UNCERTAINTIES</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><b>Regulatory inquiries</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">In the first quarter of 2021, FlexShopper, along with a number of other lease-to-own companies, received a subpoena from the California Department of Financial Protection and Innovation (the “DFPI”) requesting the production of documents and information regarding the Company’s compliance with state consumer protection laws. The Company is cooperatively engaging with the DFPI in response to its inquiry. Although the Company believes it is in compliance with all applicable consumer protection laws and regulations in California, this inquiry ultimately could lead to an enforcement action and/or a consent order, and substantial costs, including legal fees, fines, penalties, and remediation expenses.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><b>COVID-19</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">The extent of the impact and effects of the outbreak of the coronavirus (COVID-19) on the operation and financial performance of our business will depend on future developments, including the duration and spread of the outbreak, the recovery time of the disrupted supply chains, or the uncertainty with respect to the accessibility of additional liquidity or capital markets, all of which are highly uncertain and cannot be predicted. If the demand for the Company’s leases is impacted by this outbreak for an extended period, our results of operations may be materially adversely affected.</span></p>
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001397047
CY2020Q2 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
1914100 usd
us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
The Note matured on April 30, 2022 and bore interest at the rate of 1.00% per annum, payable monthly commencing on November 30, 2020, following an initial deferral period as specified under the PPP.
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
usd
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
usd
fpay Proceeds From Debt Instrument
ProceedsFromDebtInstrument
usd
CY2021Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
usd
fpay Net Income Attributables To Series1 Convertible Preferred Stock
NetIncomeAttributablesToSeries1ConvertiblePreferredStock
usd
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
usd
fpay Common Stock Optionsin Shares
CommonStockOptionsinShares
shares
fpay Common Stock Warrantsin Shares
CommonStockWarrantsinShares
shares
CY2022Q2 fpay Common Stock Warrantsin Shares
CommonStockWarrantsinShares
shares
CY2021Q4 us-gaap Fair Value Option Loans Held As Assets90 Days Or More Past Due Aggregate Difference
FairValueOptionLoansHeldAsAssets90DaysOrMorePastDueAggregateDifference
usd
CY2021Q4 us-gaap Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status Aggregated Difference
FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatusAggregatedDifference
usd
CY2022Q2 us-gaap Fair Value Option Loans Held As Assets Aggregate Difference
FairValueOptionLoansHeldAsAssetsAggregateDifference
usd
CY2021Q4 us-gaap Fair Value Option Loans Held As Assets Aggregate Difference
FairValueOptionLoansHeldAsAssetsAggregateDifference
usd
CY2021Q2 fpay Performance Share Units
PerformanceShareUnits
usd
fpay Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
fpay Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted
usd
fpay Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted
usd
CY2022Q2 fpay Share Based Compensation Arrangement By Shares Based Payment Award Options Vested And Expected To Vest Outstanding Number1
ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1
shares
CY2022Q2 fpay Share Based Compensation Arrangement By Shares Based Payments Award Options Vested And Expected To Vest Outstanding Number1
ShareBasedCompensationArrangementBySharesBasedPaymentsAwardOptionsVestedAndExpectedToVestOutstandingNumber1
shares
fpay Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod1
shares
fpay Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod1
shares
fpay Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1
shares
fpay Share Based Compensation Arrangement By Share Based Payments Award Equity Instruments Other Than Options Vested In Period1
ShareBasedCompensationArrangementByShareBasedPaymentsAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1
shares
dei Amendment Flag
AmendmentFlag
false

Files In Submission

Name View Source Status
0001213900-22-046325-index-headers.html Edgar Link pending
0001213900-22-046325-index.html Edgar Link pending
0001213900-22-046325.txt Edgar Link pending
0001213900-22-046325-xbrl.zip Edgar Link pending
f10q0622ex31-1_flexshopper.htm Edgar Link pending
f10q0622ex31-2_flexshopper.htm Edgar Link pending
f10q0622ex32-1_flexshopper.htm Edgar Link pending
f10q0622ex32-2_flexshopper.htm Edgar Link pending
f10q0622_flexshopper.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fpay-20220630.xsd Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
fpay-20220630_cal.xml Edgar Link unprocessable
fpay-20220630_def.xml Edgar Link unprocessable
fpay-20220630_pre.xml Edgar Link unprocessable
fpay-20220630_lab.xml Edgar Link unprocessable
f10q0622_flexshopper_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable